Loading organizations...
Loading organizations...
Biotechnology company developing cancer and diabetes treatments using live
PharmaCyte Biotech has raised $34.0M across 2 funding rounds.
PharmaCyte Biotech has raised $34.0M in total across 2 funding rounds.
PharmaCyte Biotech has raised $34.0M in total across 2 funding rounds.
PharmaCyte Biotech's investors include Lincoln Park Capital.
PharmaCyte Biotech has raised $34.0M across 2 funding rounds. Most recently, it raised $7.0M Series C in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 18, 2025 | $7.0M Series C | ||
| Feb 21, 2014 | $27.0M Other Equity | Lincoln Park Capital |